2Hunt SA.ACC/AHA task force on practice guideline ACC/AHA 2005 guideline update for the diagnosis and man of chronic heart failure in the adult[J].T Am Coll Cardiol,[2] 005,46(6):e1.
4MERIT-HF Study Group.Effect of metoprolo CR/XL in chronic heart failure (MERIT-HF)[J].Lancet,1999,353(9169):2001.
5Wikstrand J,Hjalmarson A,Waagstein F,et al.Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure:analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF)[J].J Am Coll Cardiol,2002,40(3):491.
6Fowler MB.Carvedilol prospective randomized cumulative survival (COPERNICUS) trial:carvedilol in severe heart failure[J].Am J Cardio,2004,93(9A):35B.
7Cleland JG,Charleoworth A,Lubsen J,et al.A comparison of the effects of carvedilol and metoprolol on well-being,morbidity,and mortality (the "patient journey") in patients with heart failure:a report from the Carvedilol Or Metoprolol European Trail (COMET)[J].J Am Coll Cardiol,2006,47(8):1603.
8Tolg R,Witt M,Schwarz B,et al.Comparison of carvedilol and metoprolol in patients with acute myocardial infarction undergoing primary coronary intervention the PASSAT Study[J].Clin Res Cardiol,2006,95(1):31.
10Goldhammer E,Maor I,Shnitzer S,et al.The early anti-oxidant effect of carvedilol predicts the clinical course in congestive heart failure patients[J].Cardiovascular Med(Haqerstown),2007,8(6):453.
3[1]Flather MD,Yusuf S,Kober L,et al.Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction:a systematic overview of data from individual patients[J].Lancet,2000,355(9215):1575-1581.
4[2]Dargie H.Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction:the CAPRICORN randomized trial[J].Lancet,2001,357(9266):1385-1390.
5[3]Dargie HJ.Design and methodology of the CAPRICORN trial:a randomized double blind placebo controlled study of the impact of carvedilol on morbidity and mortality in patients with left ventricular dysfunction after myocardial infarction[J].Eur J Heart Fail,2000,2(3):325-332.
6[4]Hunt SA.ACC/AHA task force on practice guideline.ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult[J].J Am Coll Cardiol,2005,46(6):e1-e82.
8[6]Weber K,Bohmeke T,Van der Does R,et al.Hemodynamic differences between metoprolol and carvedilol in hypertensive patients[J].Am J Hypertens,1998,11(5):614-617.
9[7]Hauf-Zacharion U,Blackwood R A,Gunawardena K A,et al.Carvedilol versus verapamil in chronic stable angina:a multicenter trial[J].Eur J Clin Pharmacol,1997,52(2):92-100.
10[8]Brunner M,Faber T,Greve B,et al.Usefulness of carvedilol in unstable angina pectoris[J].Am J Cardilol,2000,85(10):1173-1178.
